- | Page
RELIAS EXAM : BASIC PAIN
MANAGEME NT (HOSPICE) |
QUESTIONS WITH 100% CORRECT
ANSWERS | VERIFIED | UPDATED
Question : Which of the following is FALSE regarding
tricyclic antidepressants (TCAs) and their management of neuropathic pain?
- Cardiac conduction abnormalities limit their use in patients
- SSRIs have a superior analgesic effect compared to TCAs
- Anticholinergic side effects limit their use in the elderly
- Literature supports their use in post-stroke pain and pain
with arrhythmias
related to spinal cord injury
Correct answer: SSRIs have a superior analgesic effect
compared to TCAs
Question : Among the following NSAIDs, which is associated
with the highest risk of GI side effects (ulcers, bleeding)?Celecoxib (Celebrex®) Meloxicam (Mobic®)
- | Page
Ketorlac (Toradol®) Etodolac (Lodine®)
Correct answer: Ketorlac (Toradol®)
Question : Which of the following bowel regimens is MOST
appropriate for a patient taking MS Contin® 60mg PO every 12 hours and hydromorphone 2mg PO every 3 hours as needed?
Docusate sodium (Colace®) 100mg PO at bedtime
Senna-S® 1 tablet PO BID as needed
Docusate sodium (Colace®) 100mg PO BID
Senna 1 tablet PO Daily
Correct answer: Senna 1 tablet PO Daily
- | Page
Question : Which of the following pain is NOT considered
somatic pain?
Bone pain
Bowel obstruction
Muscle spasms
Pain at the incision site
Correct answer: Bowel obstruction
Question : Which of the following is FALSE regarding the
principles of pain management?
True opioid allergies are rare
Titrate doses individually for each patient
- | Page
Drug choice should be based on pain type and severity of pain
Pain is an objective measure
Correct answer: Pain is an objective measure
Question : All of the following patients are considered at risk
for poor pain assessment EXCEPT:
55 y/o diagnosed with prostate cancer with no comorbidities
85 y/o diagnosed with advanced dementia with no comorbidities
- y/o diagnosed with leukemia
45 y/o diagnosed with end-stage liver disease with a history of substance abuse
Correct answer: 55 y/o diagnosed with prostate cancer with no
comorbidities